title: Ischemia, metabolic disturbances, and arrhythmogenesis: mechanisms and management.
abstract: The development of ventricular arrhythmias is often a consequence of the interaction between structural abnormalities of the heart and transient disturbances in the electrophysiologic milieu. The critically ill patient is particularly susceptible to arrhythmias given the metabolic, ischemic, and neurohormonal stressors present in the intensive care unit. The significance of ventricular arrhythmias in the acute care setting is related to the presence of reversible causes and the extent of underlying heart disease. Long-term management of these patients is guided by an assessment of the risk for recurrent arrhythmias and the degree of left ventricular systolic dysfunction. In the absence of a reversible cause, symptomatic sustained arrhythmias are usually treated with an implantable cardioverter-defibrillator, a therapy that improves survival in this patient population. In many cases, however, proper long-term management of patients with ventricular arrhythmias is less clear, and the approach must be guided by a thorough understanding of the pathophysiology and the fundamental mechanisms of arrhythmogenesis.
authors.affiliation: Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
authors.forename: K
authors.initials: K
authors.lastname: Ramaswamy
authors.forename: M H
authors.initials: MH
authors.lastname: Hamdan
mesh_terms: D000200:Action Potentials / Q000502:physiology; D001145:Arrhythmias, Cardiac / Q000378:metabolism / Q000503:physiopathology* / Q000628:therapy; D017147:Defibrillators, Implantable; D006329:Heart Conduction System / Q000503:physiopathology*; D006439:Hemodynamics; D006801:Humans; D017202:Myocardial Ischemia / Q000503:physiopathology; D017180:Tachycardia, Ventricular / Q000503:physiopathology / Q000628:therapy